| Literature DB >> 33563959 |
Erna Davydova1, Tadahiro Shimazu2, Maren Kirstin Schuhmacher3, Magnus E Jakobsson4,5, Hanneke L D M Willemen6, Tongri Liu7, Anders Moen1, Angela Y Y Ho1, Jędrzej Małecki1, Lisa Schroer1, Rita Pinto1,8, Takehiro Suzuki9, Ida A Grønsberg1, Yoshihiro Sohtome10,11, Mai Akakabe10, Sara Weirich3, Masaki Kikuchi12, Jesper V Olsen4, Naoshi Dohmae9, Takashi Umehara12, Mikiko Sodeoka10,11, Valentina Siino5, Michael A McDonough7, Niels Eijkelkamp6, Christopher J Schofield7, Albert Jeltsch13, Yoichi Shinkai14, Pål Ø Falnes15.
Abstract
Post-translational methylation plays a crucial role in regulating and optimizing protein function. Protein histidine methylation, occurring as the two isomers 1- and 3-methylhistidine (1MH and 3MH), was first reported five decades ago, but remains largely unexplored. Here we report that METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mouse and human proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where "x" is preferably a small amino acid, allowing METTL9 to methylate a number of HxH-containing proteins, including the immunomodulatory protein S100A9 and the NDUFB3 subunit of mitochondrial respiratory Complex I. Notably, METTL9-mediated methylation enhances respiration via Complex I, and the presence of 1MH in an HxH-containing peptide reduced its zinc binding affinity. Our results establish METTL9-mediated 1MH as a pervasive protein modification, thus setting the stage for further functional studies on protein histidine methylation.Entities:
Year: 2021 PMID: 33563959 PMCID: PMC7873184 DOI: 10.1038/s41467-020-20670-7
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919